Melioidosis
12
1
1
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Environment, Pathogens, and Host Interactions in Melioidosis
An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed Melioidosis
Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients
Diagnostic Accuracy of the DPP II Assay
A Single-blind Stepped Wedge Cluster Randomized Controlled Behaviour Change Trial to Determine Effectiveness of Prevention Programme of Melioidosis in Diabetics in Ubon Ratchathani, Northeast Thailand
Co-trimoxazole as Maintenance Therapy for Melioidosis
Adapting LFI for Melioidosis
Study to Obtain Blood and Voided Urine Samples to Improve the Diagnosis of Melioidosis
Clinical Presentation of Melioidosis in Head and Neck Region
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis